Argus Investors Counsel’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Buy |
3,065
+59
| +2% | +$23.9K | 0.88% | 34 |
|
|
2025
Q1 | $1.5M | Buy |
3,006
+11
| +0.4% | +$5.47K | 1.14% | 28 |
|
|
2024
Q4 | $1.56M | Sell |
2,995
-38
| -1% | -$19.8K | 1.04% | 31 |
|
|
2024
Q3 | $1.88M | Sell |
3,033
-31
| -1% | -$19.2K | 1.22% | 29 |
|
|
2024
Q2 | $1.69M | Buy |
3,064
+60
| +2% | +$33.2K | 1.04% | 30 |
|
|
2024
Q1 | $1.75M | Sell |
3,004
-3
| -0.1% | -$1.74K | 1.07% | 29 |
|
|
2023
Q4 | $1.6M | Hold |
3,007
| – | – | 1.02% | 40 |
|
|
2023
Q3 | $1.52M | Sell |
3,007
-542
| -15% | -$274K | 1.1% | 36 |
|
|
2023
Q2 | $1.85M | Buy |
3,549
+682
| +24% | +$356K | 1.28% | 26 |
|
|
2023
Q1 | $1.65M | Sell |
2,867
-14
| -0.5% | -$8.07K | 1.25% | 28 |
|
|
2022
Q4 | $1.59M | Buy |
2,881
+67
| +2% | +$36.9K | 1.27% | 30 |
|
|
2022
Q3 | $1.43M | Buy |
2,814
+31
| +1% | +$15.7K | 1.27% | 30 |
|
|
2022
Q2 | $1.51M | Sell |
2,783
-185
| -6% | -$101K | 1.12% | 45 |
|
|
2022
Q1 | $1.75M | Buy |
2,968
+284
| +11% | +$168K | 1.12% | 48 |
|
|
2021
Q4 | $1.79M | Buy |
2,684
+233
| +10% | +$155K | 1.08% | 50 |
|
|
2021
Q3 | $1.4M | Buy |
2,451
+165
| +7% | +$94.3K | 0.92% | 53 |
|
|
2021
Q2 | $1.15M | Sell |
2,286
-204
| -8% | -$103K | 0.47% | 56 |
|
|
2021
Q1 | $1.14M | Sell |
2,490
-179
| -7% | -$81.7K | 0.46% | 53 |
|
|
2020
Q4 | $1.24M | Buy |
2,669
+83
| +3% | +$38.7K | 0.55% | 51 |
|
|
2020
Q3 | $1.14M | Buy |
2,586
+185
| +8% | +$81.7K | 0.47% | 50 |
|
|
2020
Q2 | $870K | Buy |
2,401
+611
| +34% | +$221K | 0.42% | 51 |
|
|
2020
Q1 | $508K | Buy |
1,790
+68
| +4% | +$19.3K | 0.3% | 51 |
|
|
2019
Q4 | $559K | Buy |
1,722
+156
| +10% | +$50.6K | 0.25% | 55 |
|
|
2019
Q3 | $456K | Buy |
1,566
+52
| +3% | +$15.1K | 0.22% | 59 |
|
|
2019
Q2 | $445K | Buy |
1,514
+359
| +31% | +$106K | 0.21% | 60 |
|
|
2019
Q1 | $316K | Sell |
1,155
-21
| -2% | -$5.75K | 0.15% | 69 |
|
|
2018
Q4 | $263K | Buy |
+1,176
| New | +$263K | 0.14% | 67 |
|